0828 ECP Concarlo
BioCentury & Getty Images

Emerging Company Profile

Concarlo: targeting proliferation and resistance in one go

SUNY Downstate spinout takes aim at metastatic breast cancer by targeting p27

By targeting p27, SUNY Downstate spinout Concarlo simultaneously takes aim at mechanisms of proliferation and resistance in cancer, starting with metastatic breast cancer. 

Aug 28, 2020 | 9:42 PM GMT

Concarlo is developing targeted therapies

Read the full 592 word article

How to gain access

Continue reading with a
two-week free trial.